Skip to main content

A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).

Toulon P, Ajzenberg N, Smahi M, Guillin MC

Publication: Thromb Res (2007) • Vol 119 • Page 135-43PMID: 16426667View on PubMed

Purpose

The purpose of this paper was to determine the effects of tube type, anticoagulant therapy, tube age, and reagents used on results of routine hemostasis assays.

Conclusion

Some statistically significant, but clinically irrelevant differences were seen in prothrombin time (PT), activated partial thromboplastin time (APTT), and anti-activated factor X (anti-FXa) activities between specimens collected in plastic and glass tubes that were dependent on reagent and type of anticoagulant therapy. Aging the plastic tubes within their manufacturer determined shelf life had no effects on PT, APTT, or anti-FXa activities for patients undergoing anticoagulant treatment.

Studies (1)

Purpose

The purpose of this study was to determine the effects of tube type, anticoagulant therapy, aging of tubes, and reagents used on PT, APTT, and anti-FXa activities in plasma.

Summary of Findings

When Neoplastic CI (animal thromboplastin) was used for analysis, PT values were significantly longer in specimens from non-anticoagulated patients and those on oral anticoagulant therapy collected in glass Vacutainers compared to those collected in plastic VenoSafe tubes, but when Thromborel S (human thromboplastin) was used, there were no differences in PT between collected in different tube types. APTT values also showed significant differences between specimens collected in different tube types and reagents for specimens from non-anticoagulated patients, but neither the PT nor the APTT differences were clinically relevant. Specimens from patients on unfractionated heparin or low molecular weight heparin collected in plastic VenoSafe tubes had higher anti-FXa activities than those in glass Vacutainer tubes. Further, specimens from patients on unfractionated heparin therapy collected in plastic tubes had longer APTT values than those in glass Vacutainer tubes. However, these differences were not clinically relevant. Aging the plastic tubes within their manufacturer determined shelf life had no effects on PT, APTT, or anti-FXa activities for patients undergoing anticoagulant treatment.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
  • Platforms

    ProteinHematology/ auto analyzer
    MorphologyHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionOther drugs
    Low molecular weight heparin derivative
    No anticoagulant drugs
    Oral anticoagulants
    Unfractionated heparin
    Biospecimen AcquisitionType of collection container/solution
    Vacutainer (glass)
    VenoSafe (plastic) 1 month to expiration
    VenoSafe (plastic) 8 months to expiration
    Hematology/ auto analyzer SpecificReaction solution
    Automated APTT
    Neoplastin CI
    PTT Automate
    Thromborel S